Current concepts of anti-EGFR targeting in metastatic colorectal cancer

Anti-EGFR targeting is one of the key strategies in the treatment of metastatic colorectal cancer (mCRC). For almost two decades oncologists have struggled to implement EGFR antibodies in the mCRC continuum of care. Both sidedness and RAS mutational status rank high among the predictive factors for...

Descripción completa

Detalles Bibliográficos
Autores principales: Doleschal, Bernhard, Petzer, Andreas, Rumpold, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714621/
https://www.ncbi.nlm.nih.gov/pubmed/36465407
http://dx.doi.org/10.3389/fonc.2022.1048166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714621/
https://www.ncbi.nlm.nih.gov/pubmed/36465407
http://dx.doi.org/10.3389/fonc.2022.1048166

Ejemplares similares